Open AccessRhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: Case series from the north-western part of India
Author(s) -
Hardeva Ram Nehara,
Inder Puri,
Vipin Singhal,
IH Sunil,
Bhagirath Ram Bishnoi,
Pramendra Sirohi
Publication year - 2021
Publication title -
indian journal of medical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.382
H-Index - 48
eISSN - 1998-3646
pISSN - 0255-0857
DOI - 10.1016/j.ijmmb.2021.05.009
Subject(s) - mucormycosis , medicine , covid-19 , thrombosis , diabetes mellitus , coronavirus , disease , intensive care medicine , dermatology , surgery , infectious disease (medical specialty) , endocrinology
Coronavirus disease 2019 (COVID-19), may present with a myriad of clinical manifestations and complications. Patients with COVID-19 are at increased risk of pulmonary thromboembolism, acute cardiac injury, arrhythmias, acute stroke, and secondary infections. Mucormycosis is a catastrophic fungal infection characterized by vascular invasion, thrombosis, and necrosis of tissues. We report five cases of COVID-19 infection, who developed rhino-orbital mucormycosis, during the course of treatment. Early recognition of this life-threatening infection is the key to allow for optimal treatment and improved outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom